The Food and Drug Administration has approved Unloxcyt (cosibelimab-ipdl) for advanced cutaneous squamous cell carcinoma.

The addition of adjuvant nivolumab to standard-of-care radiotherapy and cisplatin improved survival for patients with locally ...

Two months after welcoming their daughter Paloma, Jett Puckett revealed that his wife Campbell “Pookie” Puckett underwent ...

The following is a summary of “Impact of preceding treatment for head and neck squamous cell carcinoma on synchronous ...

Post-operative nivolumab significantly improved disease-free survival in resected locally advanced head and neck cancer, ...

GORTEC, known as Head and Neck Radiation Oncology Group, today announced that the randomized Phase 3 NIVOPOSTOP GORTEC ...

Medical advancements make early-detected cancers more manageable and treatable, with immunotherapy and CAR T cell therapy ...

Full House’s Dave Coulier shared how he’s been adjusting to the side effects of chemotherapy treatment amid his battle with stage 3 Non-Hodgkin’s lymphoma.

The wife of a man whose face caught on fire after medical staff at Oregon Health & Science University allegedly failed to ...

Recurrent squamous cell carcinoma in situ of the distal interphalangeal ... Final defect after two stages of Mohs surgery; note the extension of the defect toward one lateral nail fold.

IO Biotech (IOBT) announced it has completed enrollment in its neoadjuvant/adjuvant Phase 2 basket trial, IOB-032/PN-E40. The trial is studying ...

IO Biotech, Inc. (IOBT), a clinical-stage biopharmaceutical company, Thursday, announced that it has completed enrollment ahead of ...